Glaxo: UK Fraud Agency Closes Bribery Probe Into Company
February 22 2019 - 7:07AM
Dow Jones News
By Carlo Martuscelli
GlaxoSmithKline PLC (GSK.LN) said Friday that it was pleased to
note that the U.K.'s fraud watchdog closed its investigation into
the company without requiring any further action.
The Serious Fraud Office's case dates back to May 2014, when it
began to investigate the FTSE 100-listed drugmaker over bribery
charges in China. A court in the Asian country found one of Glaxo's
local subsidiaries guilty of bribery, and fined the company $491.5
million in September 2014.
Earlier in the month Glaxo had said that the SFO had requested
more information on its use of third-party advisers.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com
(END) Dow Jones Newswires
February 22, 2019 06:52 ET (11:52 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Jun 2024 to Jul 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Jul 2023 to Jul 2024
